Halozyme Therapeutics | HALO - Выручка от реализации

Биржевая цена
67.12
Изменение за день
-2.09 -3.02%
Ежемесячно
0.72%
Ежегодный
29.03%
Q2 прогноз
65.77




Продажи Изменить Дата
Acadia Pharmaceuticals USD 268.06M 15.94M 2026-03
Agios Pharmaceuticals USD 18.8M 1.17M 2026-03
Alnylam Pharmaceuticals USD 1.17B 70M 2026-03
Amarin USD 49.22M 451K 2025-12
Amgen USD 8.62B 1.28B 2026-03
Baxter International USD 2.7B 270M 2026-03
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cytokinetics USD 19.35M 1.59M 2026-03
DBV Technologies USD 2.77M 1.31M 2025-09
Eli Lilly USD 19.8B 500M 2026-03
Esperion Therapeutics USD 168.45M 81.14M 2025-12
Halozyme Therapeutics USD 377M 74.76M 2026-03
Intrexon USD 717K 511K 2024-06
Ionis Pharmaceuticals USD 246M 43M 2026-03
MannKind USD 90.2M 21.76M 2026-03
Minerva Neurosciences USD 0 0 2024-09
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Pfizer USD 14.5B 3.08B 2026-03
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
United Therapeutics USD 781.5M 8.7M 2026-03
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12